Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dexamethasone Administration”

652 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 652 results

Post-approval studies (Phase 4)Study completedNCT00917241
What this trial is testing

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

Who this might be right for
Graves' Disease
Xiao-Ming Mao 218
Large-scale testing (Phase 3)Study completedNCT01257061
What this trial is testing

Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment

Who this might be right for
Eczema
EMS 310
Not applicableStudy completedNCT02692339
What this trial is testing

Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Post-approval studies (Phase 4)WithdrawnNCT05183139
What this trial is testing

In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Takeda
Early research (Phase 1)UnknownNCT04005430
What this trial is testing

A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema

Who this might be right for
Refractory Diabetic Macular Edema
Targeted Therapy Technologies, LLC 1
Post-approval studies (Phase 4)UnknownNCT04050644
What this trial is testing

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery

Who this might be right for
Age-related Cataract
Universitaire Ziekenhuizen KU Leuven 100
Large-scale testing (Phase 3)Study completedNCT03192137
What this trial is testing

Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

Who this might be right for
Inflammation and Pain Associated With Cataract Surgery
Sun Pharmaceutical Industries Limited 260
Very early researchStudy completedNCT05620901
What this trial is testing

DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia

Who this might be right for
VitreoretinopathyCoats' DiseaseExudative Retinopathy+6 more
Lejla Vajzovic, MD, FASRS 15
Testing effectiveness (Phase 2)Study completedNCT01168804
What this trial is testing

Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 79
Very early researchUnknownNCT03237533
What this trial is testing

Treatment Modalities of Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
University of Faisalabad 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05392946
What this trial is testing

Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study

Who this might be right for
Plasma Cell Myeloma
Mayo Clinic 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166565
What this trial is testing

Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

Who this might be right for
Multiple MyelomaExtramedullary Plasmacytoma
Stichting European Myeloma Network 41
Large-scale testing (Phase 3)Ended earlyNCT02579863
What this trial is testing

Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC 310
Early research (Phase 1)Study completedNCT01065272
What this trial is testing

Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma

Who this might be right for
Bronchiolitis
Hamad Medical Corporation 200
Post-approval studies (Phase 4)Study completedNCT03900624
What this trial is testing

Ideal Steroids for Asthma Treatment in the PICU

Who this might be right for
Asthma Childhood
Johns Hopkins All Children's Hospital 92
Post-approval studies (Phase 4)UnknownNCT04038125
What this trial is testing

Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME

Who this might be right for
Diabetic Macular EdemaDiabetic RetinopathyRetinal Ischemia
Retina Macula Specialists of Miami, LLC 20
Testing effectiveness (Phase 2)Ended earlyNCT03606980
What this trial is testing

Iontophoresis With Dexamethasone and Physical Therapy to Treat Apophysitis of the Knee in Pediatrics

Who this might be right for
Apophysitis; Juvenile
Children's Health System, Inc. 45
Not applicableStudy completedNCT02608515
What this trial is testing

A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Genesis Pharma S.A. 207
Early research (Phase 1)Study completedNCT02332850
What this trial is testing

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Thomas Martin, MD 83
Next Page